Mirae Asset Global ETFs Holdings

Mirae Asset Global ETFs Holdings’s Monte Rosa Therapeutics GLUE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio GLUE Stock Details GLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$582K	Buy	35,795 +10,243	+40%	+$196K	﹤0.01%	1811
2025 Q4	$402K	Buy	25,552 +4,287	+20%	+$57.8K	﹤0.01%	1992
2025 Q3	$158K	Sell	21,265 -4,256	-17%	-$22.5K	﹤0.01%	2451
2025 Q2	$115K	Buy	25,521 +902	+4%	+$4.02K	﹤0.01%	2536
2025 Q1	$114K	Sell	24,619 -82	-0.3%	-$503	﹤0.01%	2572
2024 Q4	$172K	Buy	24,701 +2,084	+9%	+$15.6K	﹤0.01%	2458
2024 Q3	$120K	Buy	22,617 +6,347	+39%	+$32K	﹤0.01%	2627
2024 Q2	$60.9K	Buy	+16,270	New	+$83K	﹤0.01%	2739

Other funds holding GLUE

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return